Prophylactic use of interferon alfa after bone marrow transplantation for patients with chronic myelogenous leukemia at high risk of relapse: a pilot study. The Chronic Leukemia Working Party of the EBMT. [electronic resource]
- Seminars in hematology Jul 1993
- 40-3 p. digital
Publication Type: Clinical Trial; Journal Article
0037-1963
Bone Marrow Transplantation--adverse effects Feasibility Studies Graft vs Host Disease--etiology Humans Interferon-alpha--therapeutic use Leukemia, Myelogenous, Chronic, BCR-ABL Positive--pathology Pilot Projects Recurrence